Reddit Shares Plunge as It Considers Ending Google AI Partnership
Wells Fargo warns of revenue pressure but sees possible long-term upside for the platform.
Already have an account? Sign in.
Wells Fargo warns of revenue pressure but sees possible long-term upside for the platform.
GSK will buy a Chimagen trispecific T-cell engager for multiple myeloma. Phase I trials start in 2027. The deal is worth up to $750 million.
Phase 2 ADDRESS-LC missed statistical significance overall. 21 of 22 measures favored bezisterim; benefits were strongest in severe-symptom subgroups.
The catalyst: an out-of-court deal that keeps exclusive rights to onvansertib. Cash remains tight.